These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 36557713)

  • 41. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study.
    Zhang L; Xu Z; Mak JWY; Chow KM; Lui G; Li TCM; Wong CK; Chan PKS; Ching JYL; Fujiwara Y; Chan FKL; Ng SC
    J Gastroenterol Hepatol; 2022 May; 37(5):823-831. PubMed ID: 35170078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
    Viana SD; Nunes S; Reis F
    Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.
    Finlay BB; Amato KR; Azad M; Blaser MJ; Bosch TCG; Chu H; Dominguez-Bello MG; Ehrlich SD; Elinav E; Geva-Zatorsky N; Gros P; Guillemin K; Keck F; Korem T; McFall-Ngai MJ; Melby MK; Nichter M; Pettersson S; Poinar H; Rees T; Tropini C; Zhao L; Giles-Vernick T
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33472859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does the Gut Microbiome Play a Role in Obesity in Type 1 Diabetes? Unanswered Questions and Review of the Literature.
    Ismail HM; Evans-Molina C
    Front Cell Infect Microbiol; 2022; 12():892291. PubMed ID: 35873174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.
    Vestad B; Ueland T; Lerum TV; Dahl TB; Holm K; Barratt-Due A; Kåsine T; Dyrhol-Riise AM; Stiksrud B; Tonby K; Hoel H; Olsen IC; Henriksen KN; Tveita A; Manotheepan R; Haugli M; Eiken R; Berg Å; Halvorsen B; Lekva T; Ranheim T; Michelsen AE; Kildal AB; Johannessen A; Thoresen L; Skudal H; Kittang BR; Olsen RB; Ystrøm CM; Skei NV; Hannula R; Aballi S; Kvåle R; Skjønsberg OH; Aukrust P; Hov JR; Trøseid M;
    J Intern Med; 2022 Jun; 291(6):801-812. PubMed ID: 35212063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut Microbiome: A Potential Modifiable Risk Factor in Biliary Atresia.
    Jain V; Alexander EC; Burford C; Verma A; Dhawan A
    J Pediatr Gastroenterol Nutr; 2021 Feb; 72(2):184-193. PubMed ID: 33427793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
    Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes.
    Chen J; Vitetta L
    Front Biosci (Schol Ed); 2022 Aug; 14(3):23. PubMed ID: 36137978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronavirus disease 2019 and the gut-lung axis.
    Zhou D; Wang Q; Liu H
    Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z
    Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514
    [No Abstract]   [Full Text] [Related]  

  • 54. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C).
    Suskun C; Kilic O; Yilmaz Ciftdogan D; Guven S; Karbuz A; Ozkaya Parlakay A; Kara Y; Kacmaz E; Sahin A; Boga A; Kizmaz Isancli D; Gulhan B; Kanik-Yuksek S; Kiral E; Bozan G; Arslanoglu MO; Kizil MC; Dinleyici M; Us T; Varis A; Kaya M; Vandenplas Y; Dinleyici EC
    Eur J Pediatr; 2022 Aug; 181(8):3175-3191. PubMed ID: 35585256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aging and Microbiome in the Modulation of Vaccine Efficacy.
    Kumar M; James MM; Kumawat M; Nabi B; Sharma P; Pal N; Shubham S; Tiwari RR; Sarma DK; Nagpal R
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Unique Impact of COVID-19 on Human Gut Microbiome Research.
    Burchill E; Lymberopoulos E; Menozzi E; Budhdeo S; McIlroy JR; Macnaughtan J; Sharma N
    Front Med (Lausanne); 2021; 8():652464. PubMed ID: 33796545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The most important challenges ahead of microbiome pattern in the post era of the COVID-19 pandemic.
    Ejtahed HS; Hasani-Ranjbar S; Siadat SD; Larijani B
    J Diabetes Metab Disord; 2020 Dec; 19(2):2031-2033. PubMed ID: 32837956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Harnessing the Microbiome to Optimize Surgical Outcomes in the COVID-19 Era.
    Toni T; Alverdy J
    Ann Surg Open; 2021 Jun; 2(2):e056. PubMed ID: 36590034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.